Is pulmonary artery denervation via a therapeutic intravascular ultrasonic system a safe and effective treatment option for patients with PAH? In this Q&A, Alex Rothman, BM BCh, PhD, highlights what he and...
Recent updates to the major asthma guidelines have left physicians with questions on how to put these new recommendations into practice. In her session at CHEST2020, Meghan Althoff, MD, PhD, discussed the...
In this Q&A, Mehmet Kesimer, PhD, answers our questions about the potential for mucin abnormalities to help identify patients who are at risk for progressing to severe COPD–a topic he presented during...
Authors of a new meta-analysis evaluated whether the use of home noninvasive positive pressure ventilation was associated with better outcomes among patients with COPD and hypercapnia. Lead author Michael...
A research team led by Miranda P. Ween, PhD, and Laura E. Crotty Alexander, MD, performed a systematic review of recent evidence to gain more insight on the health effects of e-cigarette use. Pulmonology...
Diego J. Maselli, MD, answers our questions about choosing the right biologic for patients with severe asthma, the costs of biologics, and challenges to patient adherence to these therapies.
To determine the safety and impact of TLD on respiratory adverse events among patients with chronic obstructive pulmonary disease, a research team conducted a multicenter trial involving 82 patients....
A better understanding of the pathogenesis of chronic obstructive pulmonary disease will help create more-effective, and even preventive, therapies for patients. Lead author of a new update on the...
Maryam Navaie, DrPH, MBA, and Bartolome Celli, MD, answer our questions about their study about inhalation technique errors with metered-dose inhalers.
Sami M. Alyami, B.Pharm, MBBS, and Onofre Moran-Mendoza, MD, MSc, PhD, answer our questions about their research and session at the American Thoracic Society’s 2018 Annual Meeting. To learn more about IPF...
